Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Improving communication with multiple sclerosis patients.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
Fostering adherence to injectable disease-modifying therapies in multiple sclerosis.
Clinical studies on the efficacy and safety of Padma 28, a complex herbal formulation from Tibetan medicine: an overview.
Substituted 7-Amino-5-thio-thiazolo[4,5-d]pyrimidines as Potent and Selective Antagonists of the Fractalkine Receptor (CX3CR1).
The Incidence and Prevalence of Thyroid Disease Do Not Differ in the Multiple Sclerosis and General Populations: A Validation Study Using Administrative Data.
Perceptions of using videogames in rehabilitation: a dual perspective of people with multiple sclerosis and physiotherapists.
Spatial modeling of multiple sclerosis for disease subtype prediction.
Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
Macrophage Migration Inhibitory Factor Potentiates Autoimmune-Mediated Neuroinflammation.
Effects of pregnancy and breastfeeding on the multiple sclerosis disease course.
Transfer of myelin-reactive th17 cells impairs endogenous remyelination in the central nervous system of cuprizone-fed mice.
mTORC1 signaling and IL-17 expression: Defining pathways and possible therapeutic targets.
Effects of Brain-Derived IL-2 Deficiency and the Development of Autoimmunity on Spatial Learning and Fear Conditioning.
Whole-body in vivo monitoring of inflammatory diseases exploiting human interleukin 6-luciferase transgenic mice.
Registers of multiple sclerosis in Denmark.
Phonological fluency strategy of switching differentiates relapsing-remitting and secondary progressive multiple sclerosis patients.
Biomarkers of Inflammation and Axonal Degeneration/Damage in Patients with Newly Diagnosed Multiple Sclerosis: Contributions of the Soluble CD163 CSF/Serum Ratio to a Biomarker Panel.
Brain atrophy in natalizumab-treated patients: A 3-year follow-up.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Two decades of subcutaneous glatiramer acetate injection: current role of the standard dose, and new high-dose low-frequency glatiramer acetate in relapsing-remitting multiple sclerosis treatment.
Elevated Expression of Fractalkine (CX3CL1) and Fractalkine Receptor (CX3CR1) in the Dorsal Root Ganglia and Spinal Cord in Experimental Autoimmune Encephalomyelitis: Implications in Multiple Sclerosis-Induced Neuropathic Pain.
Viral pathophysiology of multiple sclerosis: A role for Epstein-Barr virus infection?
[Subcutaneous immunoglobulin. Treatment in chronic inflammatory demyelinating polyradiculo-neuropathy].
Multiple sclerosis: Spinal cord MRI reveals progression-related MS pathology.

Pages